UP!

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q4 2018 2019-03-08 0.00 0.00
Q3 2018 2018-11-08 -0.92 -1.02
Q2 2018 2018-08-06 -1.11 -1.20
Q1 2018 2018-05-04 -1.06 -1.06
Q4 2017 2018-02-27 -0.86 -0.98
Q3 2017 2017-11-08 -0.71 -0.85
Q2 2017 2017-08-03 -0.68 -0.78
Q1 2017 2017-05-08 -0.93 -0.93
Q4 2016 2017-03-14 -1.04 -1.04
Q3 2016 2016-11-07 -0.41 -0.41

Ratings

2016-06-14 Upgrade Wedbush Neutral to Outperform $7.00 to $10.00
2016-05-09 Reiterated Rating Needham & Company LLC Hold
2016-05-06 Reiterated Rating Wedbush Neutral $7.00
2016-03-31 Downgrade Cowen and Company Outperform to Market Perform
2016-03-16 Downgrade Needham & Company LLC Buy to Hold
2016-03-15 Reiterated Rating Wedbush Neutral $10.00 to $7.00
2015-08-11 Initiated Coverage Needham & Company LLC Buy $15.00
2015-08-10 Reiterated Rating Cantor Fitzgerald Buy $13.00
2015-05-14 Reiterated Rating Needham & Company LLC Buy $15.00
2015-04-01 Set Price Target Cantor Fitzgerald Buy $13.00
2015-04-01 Lower Price Target Needham & Company LLC Buy $21.00 to $15.00
2015-03-18 Reiterated Rating Cantor Fitzgerald Buy $13.00
2015-03-02 Downgrade Credit Suisse Outperform to Underperform $22.00 to $13.00
2015-03-02 Downgrade Credit Suisse Group AG Outperform to Underperform $22.00 to $13.00
2014-11-04 Initiated Coverage Wedbush Neutral $9.00
2014-11-03 Initiated Coverage SunTrust Buy $22.00
2014-11-03 Initiated Coverage SunTrust Banks Inc. Buy $22.00
2014-10-30 Initiated Coverage Canaccord Genuity Buy $13.00
2014-10-30 Initiated Coverage Cantor Fitzgerald Buy $13.00
2014-09-19 Upgrade Gabelli & Co Hold to Buy
2014-09-19 Upgrade Gabelli Hold to Buy $19.00
2014-06-20 Initiated Coverage Gabelli Hold
2014-04-08 Initiated Coverage Cowen and Company Outperform $22.00
2014-04-07 Initiated Coverage William Blair Outperform $25.00
2014-04-07 Initiated Coverage Needham & Company LLC Buy $21.00
2014-04-07 Initiated Coverage Credit Suisse Outperform $22.00
2016-06-14 Upgrade Wedbush Neutral to Outperform $7.00 to $10.00
2016-05-09 Reiterated Rating Needham & Company LLC Hold
2016-05-06 Reiterated Rating Wedbush Neutral $7.00
2016-03-31 Downgrade Cowen and Company Outperform to Market Perform
2016-03-16 Downgrade Needham & Company LLC Buy to Hold

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Funds

In AKAO 0 funds of 2183 total. Show all

Fund name Ticker shares

Major Shareholders

Name Relationship Total Shares Holding stocks
DUGGAN ROBERT W 40.55%  (7181002) AKAO / PCYC / PLSE /
Sonsini Peter W. 29.45%  (5215128) ABIO / AKAO / ARDX / AVEO / LOXO / ONTY / SURF / SYBX /
Florence Anthony A. Jr. 29.45%  (5215128) ABIO / AKAO / ARDX / AVEO / CVT / LOXO / ONTY / SURF / SYBX /
MOTT DAVID M 29.45%  (5215128) ABIO / AKAO / ARDX / AVEO / CLVS / CRCM / CVT / EPZM / HIVE / LOXO / ONTY / ROKA / SURF / SYBX / TSRO /
Viswanathan Ravi 29.45%  (5215128) ABIO / AKAO / ARDX / AVEO / CLVS / CRCM / CVT / EPZM / HIVE / LOXO / ONTY / ROKA / SURF / SYBX / TSRO /
Sakoda Jon 29.45%  (5215128) ABIO / AKAO / ARDX / AVEO / ONTY / OPWR /
SANDELL SCOTT D 29.45%  (5215128) ABIO / ADNC / AKAO / ARDX / AVEO / CLVS / CRCM / CVT / DATA / ECHO / EPZM / FIO / GLYC / HIVE / HPTX / INWK / LOXO / ONTY / ROKA / SNSS / SUPN / SURF / SYBX / TRGT / TSRO / VTAE / WDAY / WIFI / XOOM /
Growth Equity Opportunities IV, LLC 29.45%  (5215128) ABIO / AKAO / AVEO / ONTY /
MAKOWER JOSHUA 29.45%  (5215128) ABIO / AKAO / ARDX / AVEO / ONTY /
BASKETT FOREST 29.45%  (5215128) ABIO / ADNC / AKAO / ARDX / AVEO / CLVS / CRCM / CVT / DATA / ECHO / EPZM / FIO / HIVE / HPTX / INWK / LOXO / ONTY / ROKA / SNSS / SUPN / SURF / SYBX / TSRO / XOOM /
KOLLURI KRISHNA KITTU 29.45%  (5215128) ADNC / AKAO / ARDX / CLVS / CRCM / CVT / DATA / ECHO / EPZM / HIVE / HPTX / INWK / LOXO / ROKA / SNSS / SUPN / TSRO / XOOM /
BARRIS PETER J 29.45%  (5215128) ABIO / ADNC / AKAO / ARDX / AVEO / CLVS / CRCM / CVT / DATA / ECHO / EPZM / GLYC / GRPN / HIVE / HPTX / INWK / LOXO / ONTY / ROKA / SNSS / SUPN / SURF / SYBX / TRGT / TSRO / VTAE / WIFI / XOOM / ZHNE /
DOMAIN PARTERS VII L P 11.22%  (1987049) AKAO / CADX / CLVS / ESPR / EVOK / OREX / RGDO / TNDM / ZGNX /
ROBERTS BRYAN E 9.86%  (1746461) AKAO / CSLT / IRWD / VTAE / ZLTQ /
VENROCK ASSOCIATES IV L P 9.86%  (1746461) AKAO / ANAC /
WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST 8.90%  (1575478) AKAO / CSLT / RDUS /
ARCH VENTURE FUND VI LP 8.01%  (1418657) AKAO / FATE / PLCC /
Versant Ventures II LLC 7.04%  (1246895) AKAO / INGN /
Hillan Kenneth J. Chief Executive Officer 0.54%  (95151) AKAO / RLYP /
Wise Blake Chief Operating Officer 0.37%  (65645) AKAO / CALA /
Schilke Tobin Chief Financial Officer 0.23%  (40185) AKAO /
Friedland Ian Chief Medical Officer 0.21%  (37007) AKAO /
Swem Lee Chief Scientific Officer 0.21%  (36819) AKAO /
Halak Brian K 0.19%  (33890) ACHN / AKAO / ALIM / CADX / CLVS / DRNA / DRTX / ESPR / EVOK / OCRX / OREX / TNDM / VCYT / VNDA / ZGNX /
DOVEY BRIAN H 0.19%  (33890) ACHN / AKAO / CADX / CLVS / DRNA / DRTX / ESPR / EVOK / OCRX / OREX / OTIC / RGDO / TNDM / VCYT / ZGNX /
BLAIR JAMES C 0.19%  (33890) ACHN / AKAO / CADX / CLVS / DRNA / DRTX / ESPR / EVOK / OCRX / OREX / RGDO / TNDM / VCYT / ZGNX /
TREU JESSE I 0.19%  (33890) ACHN / AKAO / ALDX / CADX / CLVS / DRNA / DRTX / ESPR / EVOK / OCRX / OREX / RGDO / TNDM / VCYT / ZGNX /
VITULLO NICOLE 0.19%  (33890) ACHN / AKAO / CADX / CLVS / CPXX / DRNA / DRTX / ESPR / EVOK / MRNS / OCRX / OREX / RGDO / TNDM / VCYT / ZGNX /
SCHOEMAKER KATHLEEN K 0.19%  (33890) ACHN / AKAO / CADX / CLVS / DRNA / DRTX / ESPR / EVOK / OCRX / OREX / RGDO / TNDM / VCYT / ZGNX /
DP VII ASSOCIATES LP 0.19%  (33890) AKAO / CADX / CLVS / ESPR / EVOK / OREX / TNDM / ZGNX /
Sarpangal Zeryn VP, HR and Corporate Affairs 0.14%  (24022) AKAO /
LOEB GARY General Counsel 0.08%  (13333) AKAO / AMRS /
BERTOCCI DEREK A SVP and CFO 0.07%  (11854) AKAO / ARAY /
Murray Christine VP, Regulatory Affairs 0.06%  (10000) AKAO /

Comments